Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumors.

Fukamachi H, Seol HS, Shimada S, Funasaka C, Baba K, Kim JH, Park YS, Kim MJ, Kato K, Inokuchi M, Kawachi H, Yook JH, Eishi Y, Kojima K, Kim WH, Jang SJ, Yuasa Y.

PLoS One. 2013 Aug 28;8(8):e72438. doi: 10.1371/journal.pone.0072438. eCollection 2013.

2.

High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures.

Penfornis P, Cai DZ, Harris MR, Walker R, Licini D, Fernandes JD, Orr G, Koganti T, Hicks C, Induru S, Meyer MS, Khokha R, Barr J, Pochampally RR.

Cancer Med. 2014 Aug;3(4):796-811. doi: 10.1002/cam4.249. Epub 2014 May 7.

3.

CD49f-positive cell population efficiently enriches colon cancer-initiating cells.

Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.

Int J Oncol. 2013 Aug;43(2):425-30. doi: 10.3892/ijo.2013.1955. Epub 2013 May 24.

PMID:
23708747
4.

Identification of gastric cancer stem cells using the cell surface marker CD44.

Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC.

Stem Cells. 2009 May;27(5):1006-20. doi: 10.1002/stem.30.

5.

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.

6.

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.

Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q, Chen H.

Oncogene. 2012 May 24;31(21):2614-26. doi: 10.1038/onc.2011.439. Epub 2011 Sep 26.

7.

Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.

Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z.

Oncogene. 2012 Feb 9;31(6):671-82. doi: 10.1038/onc.2011.282. Epub 2011 Jul 11.

PMID:
21743497
8.

Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.

Michishita M, Akiyoshi R, Yoshimura H, Katsumoto T, Ichikawa H, Ohkusu-Tsukada K, Nakagawa T, Sasaki N, Takahashi K.

Res Vet Sci. 2011 Oct;91(2):254-60. doi: 10.1016/j.rvsc.2010.11.016. Epub 2010 Dec 28.

PMID:
21190702
9.

Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties.

Bragado P, Estrada Y, Sosa MS, Avivar-Valderas A, Cannan D, Genden E, Teng M, Ranganathan AC, Wen HC, Kapoor A, Bernstein E, Aguirre-Ghiso JA.

PLoS One. 2012;7(1):e29974. doi: 10.1371/journal.pone.0029974. Epub 2012 Jan 20.

10.

CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.

Yamamoto H, Masters JR, Dasgupta P, Chandra A, Popert R, Freeman A, Ahmed A.

PLoS One. 2012;7(10):e46979. doi: 10.1371/journal.pone.0046979. Epub 2012 Oct 12.

11.

CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.

Lau WM, Teng E, Chong HS, Lopez KA, Tay AY, Salto-Tellez M, Shabbir A, So JB, Chan SL.

Cancer Res. 2014 May 1;74(9):2630-41. doi: 10.1158/0008-5472.CAN-13-2309. Epub 2014 Mar 11.

12.

Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.

Ying M, Liu G, Shimada H, Ding W, May WA, He Q, Adams GB, Wu L.

Oncogene. 2013 Sep 5;32(36):4252-63. doi: 10.1038/onc.2012.438. Epub 2012 Oct 8.

13.

CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.

Shi CJ, Gao J, Wang M, Wang X, Tian R, Zhu F, Shen M, Qin RY.

World J Gastroenterol. 2011 Jun 28;17(24):2965-71. doi: 10.3748/wjg.v17.i24.2965.

14.

Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research.

Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ, Shim HE, Yoon S, Baek SY, Kim BS, Kang CD, Oh SO.

Cell Mol Life Sci. 2011 Nov;68(21):3589-605. doi: 10.1007/s00018-011-0672-z. Epub 2011 Mar 30.

PMID:
21448722
15.

CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.

Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G.

J Cell Physiol. 2012 Jun;227(6):2686-93. doi: 10.1002/jcp.23013.

PMID:
21898409
16.

Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.

Yan B, Stantic M, Zobalova R, Bezawork-Geleta A, Stapelberg M, Stursa J, Prokopova K, Dong L, Neuzil J.

BMC Cancer. 2015 May 13;15:401. doi: 10.1186/s12885-015-1394-7.

17.

Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.

Chen CL, Tsukamoto H, Liu JC, Kashiwabara C, Feldman D, Sher L, Dooley S, French SW, Mishra L, Petrovic L, Jeong JH, Machida K.

J Clin Invest. 2013 Jul;123(7):2832-49. doi: 10.1172/JCI65859. Epub 2013 Jun 10.

18.

Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.

Rainusso N, Man TK, Lau CC, Hicks J, Shen JJ, Yu A, Wang LL, Rosen JM.

Cancer Biol Ther. 2011 Aug 15;12(4):278-87. Epub 2011 Aug 15.

19.

The CD49d+/high subpopulation from isolated human breast sarcoma spheres possesses tumor-initiating ability.

Lee KM, Han W, Kim JB, Shin I, Ko E, Park IA, Lee DS, Oh K, Noh DY.

Int J Oncol. 2012 Mar;40(3):665-72. doi: 10.3892/ijo.2011.1289. Epub 2011 Dec 8.

PMID:
22159714
20.

What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.

Qureshi-Baig K, Ullmann P, Rodriguez F, Frasquilho S, Nazarov PV, Haan S, Letellier E.

PLoS One. 2016 Jan 8;11(1):e0146052. doi: 10.1371/journal.pone.0146052. eCollection 2016. Erratum in: PLoS One. 2016;11(2):e0150179.

Supplemental Content

Support Center